OGN Wutah bathi saben saham ing taun iki Organon & Co.

Simbol resmi perusahaan Organon Pharma (OGN)

Year-over-year EPS growth demonstrates the dominance of Organon & Co. (OGN) in the women's health niche and high margins. The current status is -8.50. Organon & Co. is actively investing in biotechnological developments and reproductive medicine. A global network of plants and protected patents ensure the uninterrupted production of high-demand contraceptives.

Wutah bathi saben saham ing taun lumaku: Organon & Co (OGN) kanggo 04.07.2022 - 12.11.2026

Rincian metrik keuangan lan pasar Organon & Co. (OGN)

- nilai saham lan prakiraan konsensus rega:
Rega bursa Organon & Co|OGN - Bagan rega target
- data kapitalisasi pasar:
Kapitalisasi pasar Organon Pharma|OGN - Nilai Total Perusahaan
- informasi kapitalisasi buku:
Nilai Aset Bersih saben Saham Organon|OGN - Nilai Buku Perusahaan|Nilai Pasar marang Nilai Buku organon.com|OGN - Total Aset Perusahaan
- rincian utang lan likuiditas:
Rasio Utang marang Modal Organon & Co.|OGN - Utang jangka dawa marang modal|Utang jangka cendhak marang modal organon.com|OGN - Utang perusahaan|Rasio utang marang nilai buku Organon Pharma|OGN - Utang jangka dawa perusahaan|Utang jangka cendhak Organon|Rasio likuiditas darurat organon.com
- indikator profitabilitas perusahaan lan kelipatan valuasi:
OGN - Penghasilan resik|Penghasilan resik sing dikarepake Organon & Co.|OGN - Pangali rega marang bathi|Rasio kapitalisasi marang bathi mangsa ngarep Organon Pharma|OGN - Pangali rega marang bathi tumrap wutah|Nilai bisnis marang bathi operasional sadurunge panyusutan Organon Pharma|OGN - Bathi operasional EBITDA|Bathi resik saben saham sajrone 12 wulan pungkasan Organon|OGN - Bathi saben saham sajrone rolas wulan pungkasan|Wutah bathi saben saham ing petungan tahunan sajrone rolas wulan pungkasan organon.com|OGN - Wutah bathi resik saben saham ing taun iki|Prakiraan konsensus wutah bathi saben saham kanggo taun ngarep Organon & Co.
Analisis dhasar perusahaan:Organon & Co
Produk asli Organon & Co.

The integration of AI platforms and robotic assembly lines into Organon & Co. (OGN) production directly impacts annual net earnings per share dynamics by optimizing operating expenses. This indicator measures the percentage deviation of current EPS from the value of the same period last year, allowing investors to assess real capital resilience regardless of short-term market volatility and inflated expectations.

Pesaing utama

Kacepetan wutah bathi saben saham ing taun lumaku Dare Bioscience (DARE)|Wutah bathi saben saham ing taun lumaku TherapeuticsMD Inc|Wutah bathi saben saham ing taun iki PTN (Palatin Corp)